The article of Ukrainian scientists on hematopoietic stem cells was published in the prestigious international journal

10.08.2015 |

In 2015, the article of the team of scientists from the Institute of Cell Therapy, entitled “Comparative Analysis of the Hematopoietic Progenitor Cells from Placenta, Cord Blood, and Fetal Liver, Based on Their Immunophenotype”by the authors Maria D. Kuchma, Vitaliy M. Kyryk, Hanna M. Svitina, Yulia M. Shablii, Lubov L. Lukash, Galina S. Lobyntseva, and Volodymyr A. Shablii was published in the prestigious international journal BioMed Research International.

Journal BioMed Research International was founded in 2001 and is indexed in the most significant scientometric databases, in particular Scopus and Pubmed. The impact factor of the journal to date is 1.5. All articles submitted to the journal BioMed Research International, are carefully reviewed by independent experts, and only about 40% of the submitted papers are published. Therefore, publication of the article in this journal for any scientist is a confirmation of the importance and high quality of the studies.

But this is not the first international recognition of Ukrainian scientists in the field of stem cell research. The achievements of the research Institute of Cryobiology and Cryomedicine (Kharkiv), research Institute of Emergency and Reconstructive Surgery n.a. VK. Gusak (Donetsk), Institute of Cell Therapy (Kiev) are world famous. In Ukraine, in 1984 Europe’s first cord blood bank was created. And the first transfusion of umbilical cord blood was performed in Ukraine in 1933 by MS Malinowski. In 2014, at the conference of the International Placenta Stem Cells Society (IPLASS) in Granada (Spain), deputy director of the cryobank of the Institute of Cell Therapy VA Shabliy, PhD was awarded for the best report on the biological properties of placental stem cells.

In the article “Comparative analysis of hematopoietic progenitor stem cells from the placenta, cord blood and fetal liver based on their immunophenotype” team of scientists from the Institute of Cell Therapy presented characterization of human hematopoietic stem cells with the phenotype CD34+CD45lowSSClow isolated from term placentas, cord blood and fetal liver. The results of these studies are a prerequisite for the practical implementation of technologies of banking and clinical application of stem cells of the placenta in Ukraine.